Event 
Medical 
Corporate 
2020-08-20
Business Opportunities in Genomics-Using genomic profiling to find suitable targeted drugs
Through ideal medical perspective, genomic profiling can also enable patients to maintain normal life and quality beside providing suitable medical solutions.
Published:
Hong Kong
Author(s):
2020-08-20
Business Opportunities in Genomics-New targeted drugs for lung cancers
NGS can help cancer patients treat cancer with the right drugs, and through more targeted drugs, it will be easier to treat lung cancer.
Published:
Hong Kong
Author(s):
2020-08-03
The special disease progress of a 62-year-old lung cancer patient is controlled after performing genomic profiling sequencing twice
The treatment options for late-stage lung cancer treatment are limited and NGS can overcome brain metastases mostly seen in late-stage.
Published:
Taipei
Author(s):
2020-07-27
Genomic profiling can find right drug for late-stage ovarian cancer patients
Cancer genomic profiling is the key to prevent recurrence of late-stage ovarian cancer. Sequencing 48 DNA repair genes at once can find right targeted drugs to extend the PFS of ovarian cancer patients.
Published:
Taipei
Author(s):
2020-07-13
Business Opportunities in Genomics- Provide subsidy in cancer genomics profiling service
Since 2020 July, ACT Genomics and pharmaceutical care foundation cooperate on the yearly program to subsidize cancer genomic profiling for patients to find drugs. Please visit-> http://www.pcfhk.org/hk/pharmacy?id=30
Published:
Hong Kong
Author(s):
2020-06-29
Business Opportunities in Genomics- The public & private development of genomics
The Food and Health Bureau of the Government of the Hong Kong Special Administrative Region and universities provide solid foundation for genomic profiling, while private company can accelerate market maturity and provide solutions in short terms.
Published:
Hong Kong
Author(s):
2020-06-19
Decode Melanoma In Asian Patients Through Collaboration Among ACT Genomics, KMU and NHRI
To treat Melanoma, immunotherapy shows only half effect in Asian patients comparing to Western patients. ACT Genomics is working with KMU and NHRI to find better treatment for Asians.
Published:
Taipei
Author(s):
2020-06-16
ACT Genomics is the first one to receive Taiwan LDTS
Laboratory Developed Tests and Services, LDTS is the new tread which affecting out quality of medical treatment, and ACT Genomics is the first one to receive Taiwan LDTS. Let's see how ACT Genomics reaches hits high-quality control.
Published:
Taipei
Author(s):
2020-06-15
Business Opportunities in Genomics- The present & future of genomics
The genomics plan in Asia is speeding up and The Food and Health Bureau of the Government of the Hong Kong Special Administrative Region establishes Hong Kong Genomics Center to implement the plan of Hong Kong genomics research and ACT Genomics will provi
Published:
Hong Kong
Author(s):
2020-06-05
Business Opportunities in Genomics- Innovative genomic profiling can fight brain cancer
Performing NGS cancer genomic profiling through CSF liquid biopsy can overcome tumor biopsy difficulties in brain and allows more genomic mutations to be detected for accurate therapy than blood sample.
Published:
Hong Kong
Author(s):
